ランキング価格はじめての方へ
  1. 米国企業
  2. Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc.NVOS

時価総額
$443万
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
8月31日		2018年
8月31日		2019年
8月31日		2020年
8月31日		2021年
8月31日		2022年
8月31日
Net loss-------745,264-2,117,193-403,579-4,924,209-4,470,935-33,045,178
Depreciation and amortization---------123
Fair value of vested stock options------------426,690
Common stock issued for services-----------1
Operating lease expense--------214,893541,530642,991852,580
Amortization of debt discount33,858180,461296,258--------6
Foreign currency transaction losses-----------641,643
Gain on forgiveness of debt--------377,300-21,900-
Impairment of assets-----------14
Other receivables write-off-----------299,672
Goodwill impairment-----------1
Accounts receivable------289,316263,152151,254229,015-1,103,800-457,006
Inventory-----------527,397
Prepaid expenses and other current assets------84,161-23,24491,097-61,21843,194369,647
Accounts payable325,128326,936354,98167,658-35,4306,538-412,877-331,870-140,093-275,895-45,228283,234
Accrued expenses305,506300,506301,90634,205--89,93758,328-172,309-15,591-287,03438,743
Accrued interest14,95522,38429,34118,35424,066-310,790316,22895,815114,8159,015101,353
Operating lease liability-----------618,645-806,394
Net cash used in operating activities--------934,501-822,268-441,694-1,024,802-5,884,145
Purchase of property and equipment------38,238178,626107,63512,110255,949190,168
Cash acquired with acquisition------12,249---457,489
Amounts loaned for other receivables-------38,604225,924-473,100-
Collection of other receivable-----------296,138
Net cash provided by investing activities--------217,230-842,914657,1303163,459
Receipts from (repayments to) related parties-------85,063----16,600
Repayments of notes payable------131,4546,997--311
Repayments of finance leases-----------18,435
Proceeds from issuance of convertible notes894,75011-17,914------15
Repayment of convertible notes23,00023,00066,200--------5
Proceeds from the sale of common stock, net of offering costs44472,849170,000150,000315,5643113,3997-
Proceeds from exercise of stock options45,00045,00045,000-------12,000-
Net cash (used in) provided by financing activities--------11,5743-271,6874-427,117
Effect of exchange rate changes on cash and cash equivalents---------56840,303-65,73833,328
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS--------1-15,9486-6,114,475
Interest------186,618240,366129,45995,219144,9872
Common stock issued for convertible debt-----------1
Common stock issued for acquisition----------430,8372
Warrants issued with convertible notes-----------6